Moderna, Inc. (MRNA)
248.69
-2.14
(-0.85%)
USD |
NASDAQ |
Nov 11, 16:00
245.53
-3.16
(-1.27%)
After-Hours: 20:00
Moderna Net Income (Quarterly) : 162.00M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 162.00M |
| June 30, 2026 | -782.00M |
| March 31, 2026 | -1.343B |
| December 31, 2025 | -826.00M |
| September 30, 2025 | -200.00M |
| June 30, 2025 | -825.00M |
| March 31, 2025 | -971.00M |
| December 31, 2024 | -1.12B |
| September 30, 2024 | 13.00M |
| June 30, 2024 | -1.279B |
| March 31, 2024 | -1.175B |
| December 31, 2023 | 217.00M |
| September 30, 2023 | -3.63B |
| June 30, 2023 | -1.38B |
| March 31, 2023 | 79.00M |
| December 31, 2022 | 1.465B |
| September 30, 2022 | 1.043B |
| June 30, 2022 | 2.197B |
| March 31, 2022 | 3.657B |
| Date | Value |
|---|---|
| December 31, 2021 | 4.868B |
| September 30, 2021 | 3.333B |
| June 30, 2021 | 2.78B |
| March 31, 2021 | 1.221B |
| December 31, 2020 | -272.48M |
| September 30, 2020 | -233.64M |
| June 30, 2020 | -116.71M |
| March 31, 2020 | -124.23M |
| December 31, 2019 | -124.24M |
| September 30, 2019 | -123.22M |
| June 30, 2019 | -134.94M |
| March 31, 2019 | -132.58M |
| December 31, 2018 | -141.43M |
| September 30, 2018 | -80.33M |
| June 30, 2018 | -90.60M |
| March 31, 2018 | -72.38M |
| December 31, 2017 | -37.94M |
| September 30, 2017 | -64.78M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -407.46M |
| Vaxcyte, Inc. | -297.06M |
| Twist Bioscience Corp. | -35.05M |
| BioNTech SE | 212.27M |
| Vir Biotechnology, Inc. | -96.25M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.313B |
| Total Expenses (Quarterly) | 1.151B |
| EPS Diluted (Quarterly) | 0.3791 |
| Enterprise Value | 99.53B |
| Gross Profit Margin (Quarterly) | 70.60% |
| Profit Margin (Quarterly) | 12.34% |
| Earnings Yield | -2.85% |
| Normalized Earnings Yield | -2.852 |